CHRISTMAS COMES EARLY FOR CHILDREN WITH CANCER COURTESY OF PM-INTERNATIONAL MALAYSIA
more
Stories about Medizin
- Language:
- Media:
- Period:
- Period:Total
Artificial intelligence in the healthcare sector: Lindera successfully closes financing round of six million euros
moreAlmirall delivers solid nine months 2021 results and tightens its upgraded guidance
Barcelona, Spain (ots/PRNewswire) - - Strong Core business performance with growth in Core Net Sales EUR601.7 MM (+6.2% year-on-year) and Core EBITDA reaching EUR164.2 MM, (+20.3% year-on-year) driven by positive contribution from Growth Drivers and a strong EU dermatology performance - Key Growth Drivers underpinning increase in Core Net Sales. Strong performance from ...
moreIEVA (Independent European Vape Alliance)
Tobacco Harm Reduction is critical if we are to reduce smoking related disease rates worldwide
Brussels (ots) - Eight million smokers worldwide die from a smoking-related disease every year. [1] Tobacco Harm Reduction is a chance for smokers to switch from an extremely harmful to a significantly less harmful alternative. [2] Unfortunately, the WHO has lost sight of this in recent years. But it is not too late to repent. It must focus on the future of millions of ...
moreShockwave therapy brings new healing opportunities for heart attack patients and hope for people with spinal cord injuries
Vienna (ots) - Success Story of Extracorporeal Shock Wave Therapy (ESWT) Successful for over 40 years in urology for the disintegration of kidney stones, with high efficiency and hardly any side effects worth mentioning. How does the shock wave work? Without causing mechanical damage, shockwaves trigger a biological ...
more- 2
German MECOTEC Group delivers 8 containers for deep-freeze storage of Covid-Vaccines
more
New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
moreAlmirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice
Barcelona, Spain (ots/PRNewswire) - - Psoriasis affects the overall emotional wellbeing of 88% of patients[1], and at least 20% of psoriasis patients have considered suicide[2] - Currently used endpoints in psoriasis do not capture the full impact of this skin condition on patients' lives, and almost 50% of them ...
moreEleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-art, 500 l single-use reactors from Sartorius Stedim Systems. The scale-up will enable Eleva to enter ...
moreGold Standard Diagnostics Europe
Novatec and Virotech to become Gold Standard Diagnostics Europe
Dietzenbach (ots) - The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to ...
moreLebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...
moreM3 Invests in Physicians Career Portal praktischArzt
more
Aircraft Cabin Modification GmbH
3Avital increases safety in aviation
moreSysmex Inostics presents data at ASCO
Baltimore, MD (ots) - Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is presenting the poster ...
moreInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
moreDid my vaccine work? New rapid test for the determination of vaccination success
moreFluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test
moreFluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry
more
Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients
Baltimore, MD, USA (ots) - Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster “Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients” at the 112th Annual Meeting of the American Association for Cancer ...
moreFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
moreHitachi Medical Systems Europe Holding AG
2Hitachi Medical Systems Europe (HMSE): The new "Plus" in human-centered open MRI is taking off at ECR 2021 with "SynergyDrive", the suite for streamlined workflow and high-speed exams
more- 2
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
more European Society for Medical Oncology (ESMO)
Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research
moretFRWD LAUNCHES COVID-19 PCR SELF TEST TO DO AT HOME (SALIVA BASED)
Vienna (ots) - In partnership with local distributor DIVISIONCARE, tFRWD is ready to supply large numbers of the test-kits to the Portuguese. The test is done through RT.PCR and the kit is CE certified and approved by WHO with a sensitivity / specificity of 99%. This is the first Covid19 self-test solution to perform at home, completely painless, and without needing a health professional to collect the sample. Tester ...
more
Prof. Dr. Heino Stöver - Sozialwissenschaftliche Suchtforschung
Expert for addiction studies, Prof. Dr. Heino Stöver, criticizes the new EU Beating Cancer Plan: "Target of less than 5 percent of smokers in the EU not achievable without harm reduction approach".
Frankfurt/Main (ots) - Prof. Dr. Heino Stöver has sharply criticized the EU Commission's "Beating Cancer Plan" presented today: "For years, the always same methods have been used trying to attain the ambitious goals of an almost tobacco-free continent. Tax increases, advertising bans and no-smoking zones are too ...
moreMerger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
moreCOVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease
Moers (ots) - Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with ...
moreCorona rapid test: Celebrate Christmas together without anyone getting infected
moreSysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...
moreNew study: Only reliable rapid corona tests make sense
more
Previous12345678Next